Lumentum Holdings Inc. (LON:0JVV)

Revance Therapeutics Revenue

In the fiscal year ending June 28, 2025, Lumentum Holdings had annual revenue of $1.65B USD with 21.03% growth. Lumentum Holdings had revenue of $480.70M in the quarter ending June 28, 2025, with 55.92% growth.

• Revenue: $1.65B
• Revenue Growth: +21.03%
• P/S Ratio: 5.16
• Revenue / Employee: $226.68K
• Employees: 7,257
• Market Cap: 6.18B

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 28, 2025	1.65B	285.80M	21.03%
Jun 29, 2024	1.36B	-407.80M	-23.08%
Jul 1, 2023	1.77B	54.40M	3.18%
Jul 2, 2022	1.71B	-30.20M	-1.73%
Jul 3, 2021	1.74B	64.20M	3.82%